Longitudinal IgG recognition patterns of viral proteins were studied in 15 men who had seroconverted for lymphadenopathy associated virus/human T lymphotropic virus (LAV/HTLV-II). Antibodies to the major viral core protein p24, which is a cleavage product ofthe gag gene encoded precursorprotein pr55, appeared first. These were soon followed by antibodies to pr65 and more gradually by antibodies to the other gag gene encoded cleavage product p18, the env gene encoded transmembrane glycoprotein gp4l, the env gene encoded glycoproteins gp65 and gpllO, and the putative pol gene product p33.
Fourteen patients were assigned to receive amiodarone and 23 placebo. Two patients (one in each group) died before the end of the study.
Detection ofautoantibodies-None of the patients treated with placebo had or developed autoantibodies. On day 1 none of the patients treated with arniodarone had detectable autoantibodies. On day 7 three of the 13 surviving patients treated with amiodarone had detectable antithyroid microsomal antibodies, and on day 30 six had them (55%). Tests for all other autoantibodies yielded negative results in both groups.
Thyroid function-The table shows the serum concentrations of triiodothyronine, thyroxine, and thyroid stimulating hormone. No differences were seen in triiodothyronine and thyroxine concentrations between the two groups. A significant difference in concentrations of thyroid stimulating hormone between the two groups was noted on day 30 (p<005). In three patients treated with amiodarone the concentration of thyroid stimulating hormone rose to the hypothyroid range , and mU/l). Two of these three patients had antithyroid antibodies.
Discussion
The finding ofthyroid antibodies in 55% ofpatients after they had been taking amiodarone for 30 days suggests that this drug has a toxic effect on the thyroid even when taken for fairly short periods. Previously such antibodies have been reported only in patients given long term treatment.3 Follow up evaluation six months after the withdrawal of amiodarone in the seven patients who had detectable antimicrosomal thyroid antibodies showed complete clearance ofthe autoantibodies. Similarly, concentrations ofthyroid stimulating hormone in these patients reverted to normal. Thus the toxic effect seems to be reversible when the drug is used for short periods.
Introduction
Lymphadenopathy associated virus (LAV),' 2 also designated human T lymphotropic virus type III (HTLV-III),3 is the causative agent of acquired immunodeficiency syndrome (AIDS). IgG antibodies to LAV/HTLV-III are found in nearly all patients with AIDS or signs preceding AIDS, whereas they are virtually absent in populations not at risk.4' Furthermore, LAV/HTLV-III can be isolated from many subjects with AIDS or signs preceding AIDS,8 and transmission of the virus by blood transfusion has led to the subsequent developmnent of AIDS.9 10 In a Swiss seroepidemiological study Schupbach et al found evidence for the following pattern of IgG antibody response in human LAV/HTLV-III infection: in early and asymptomatic infection antibodies to the gag gene encoded protein p24" 12 predominate, whereas in later and symptomatic infection antibodies to the env gene product gp4l" 12 are found most consistently, and with progression to AIDS antibody titre to p24 declines or disappears. '3 We present data on the protein recognition patterns of LAV/ HTLV-III in sequential serum samples from 15 individuals, two of whom eventually developed AIDS, that were followed from seroconversion to a maximum of three and three quarters years later.
Subjects and methods
Sequential serum samples obtained from 13 homosexual men who participated in a study ofthe efficacy ofhepatitis B vaccine between 1980 and 1982'4 and had seroconverted for LAV/HTLV-III'5 were studied. Blood was collected at monthly intervals during the initial five months of the trial and every three months thereafter. In these 13 subjects the average time from the last serum sample that was negative for anti-LAV/HTLV-III to the first that was positive for anti-LAV/HTLV-III was 10-9 weeks (range 1-16 weeks). One subject developed AIDS three years after seroconversion. Six men entered a new prospective study on AIDS, which started in October 1984.
For the whole group the average length offollow up after seroconversion was 109 5 weeks (range 
weeks).
Apart from this group two other subjects who had seroconverted were studied. One subject had seroconverted after receiving a blood transfusion and developed AIDS two and a half years later. The other person, whose clinical history has been described elsewhere, had a transient mononucleosis like illness two weeks after sexually acquired LAV/HTLV-III infection.'6 Both subjects were followed up for 134 weeks after seroconversion.
IMMUNOBLOT ANALYSIS
Heat inactivated LAV/HTLV-III purified with a sucrose gradient was fractionated by electrophoresis using a 12% polyacrylamide slab gel in the presence of sodium dodecylsulphate. ' Proteins pl8gag, p24aag, and pr55a-g were considered to be encoded by the gag gene; proteins gp4lenv, gp65env, and pri loenv by the env gene," 12; and protein p33Pol by the pol gene.20
Results

PROTEIN RECOGNITION PATTERNS OF LAV/HTLV-III
In all 15 subjects studied the first positive serum sample reacted with p24aag. Reactivity against pr559ag was also often detected at this time, whereas it usually took longer for the other proteins to be recognised (figs 1 throughout the observation period, even when this was longer than three years (cases 3 and 4 in fig 1) . In two subjects AIDS developed. One of these patient's clinical history has been described fully elsewhere.'5 Two and a half years after seroconversion he developed AIDS related complex, and half a year later AIDS was diagnosed. At the time he developed AIDS related complex his immunoblot pattern did not show p24Pag, while the only other protein that was clearly present before this time, gp4lenv, decreased in intensity but remained visible until his death over a year later. The second patient (case 1, fig 1) was a heterosexual man who received multiple blood transfusions in June 1982. Seroconversion for LAV/HTLV-III occurred in July 1982. Two years later malaise, fever, and weight loss developed. AIDS was diagnosed two and a half years after seroconversion when he developed candida oesophagitis. Examination of his last two serum samples, taken 54 and 134 weeks after seroconversion, showed-a gradual diminishing in the intensity of the protein bands, especially of pl8gag and p24gag.
Discussion
As found in studies of experimental infection in non-human primates2' and in humans,22 we found that the early antibody response against LAV/HTLV-III was directed predominantly against gag gene products (especially p24 and pr55) and followed gradually by a response directed against env gene products (especially gp4l and gp65) and the pol gene product (p33). The earliest IgG response was directed against p24gag. In the subject in whom the precise time of LAV/HTLV-III transmission was known the lag time between infection and recognition of p245ag was between two and four weeks.
Not only did antibodies against p249ag indicate the early phase of LAVIHTLV-III infection but they also provided information in later infection. In subjects without AIDS the intensity of the gp en" were studied not all were tested at each subsequent interval and not all were followed up for 156 weeks. At each interval shown, however, at least six subjects were tested.
response against all the different visible proteins stabilised or increased with time even when they were followed up for three years. As Biggar et al reported, recently,22 we found in the two subjects in whom AIDS eventually developed that the intensity of the response against the different proteins started to dLiminsh, most noticeably for gag encoded proteins, two and a half years and one year after seroconversion, respectively. In one ofthese patients total eradication of p248ag coincided with the onset of AIDS related symptoms, whereas gp4lenv remained visible to his death. Schupbach et al tentatively concluded from transsectional data that decline or loss of antibody titre to p24gag signifies impending transition to AIDS'3; findings from our longitudinal study support this. Whether the decline of anti-p24ga titre is due to excessive production of viral antigen in progressive. symptomatic LAV/ HTLV-III infection or to exhaustion of B cell lines producing antip24gag, or both, has yet to be investigated. (Accepted 9December 1985) 100 YEARS AGO A curious case of early puberty was shown by Mr. Bruce Clarke at the meeting of the Pathological Society on January 19th. A large muscular boy, apparently ten or twelve years old, came utder treatment on account of bowing of the tibiu due to rickets, and the parents made the astonishing statement that he was born on May 17th, 1882, a statement subsequently confirmed bya reference to thebirth-certificate preserved at SomersetHouse. He was three feet eight and a half inches high, and weighed four stone six pounds. There was some down on his cheek, and, though there was no hair on the chest or in the armpits, he was as hairy as a man about the pubes and in the perunuum. His penis was as large as a man's, and was noticed to be erect every morning, though the testicles were rather smaller than those of an adult. The pomum Adami was well developed, and his voice was cracked like that of a boy losinghis "childishbtreble." The development ofhis brain, however, had not kept pace with the growth ofhis body, and his mental state was about that of a child of his years. The girth of the head round the occipital and frontal protuberances was twenty-one inches, which is certainly not very small for his bulk. It is interesting to note that, in spite of the great development ofhis sexual organs, he has never given any evidence of sexual desire, and that no seminal emissions are known-to have occurred. The boy was the third child in a family of five, and he was bigger than the eldest child, who was over seven years old. He was suckled for nine months. At about one year of age he began to grow rapidly and to eat voraciously, so that nothing seemed to satisfy him. Hair began to grow on the pubes, and, before he was a year and a half old, he was as hairy as a man. At about that time this very rapid rate ofgrowth ceased, and, since then, his mother thinks he has only grown with ordinary rapidity. Mr. Bruce Clarke performed osteotomy on the bowed tibin, and the boy made a good recovery. A few cases are on record where puberty developed between the ages of two and three years, but Mr. Clarke informs us that he has been unable to find any other case recorded where it developed. before eighteen months of age.
(British MedicalJownal 1886;i:263.)
